Phase I clinical evaluation of seasonal influenza hemagglutinin (HA) DNA vaccine prime followed by trivalent influenza inactivated vaccine (IIV3) boost.
| Autor: | Ledgerwood, Julie E.1 Ledgerwood@mail.nih.gov, Hu, Zonghui2, Costner, Pamela1, Yamshchikov, Galina1 yamshchikovgv@mail.nih.gov, Enama, Mary E.1, Plummer, Sarah1, Hendel, Cynthia S.1, Holman, Lasonji1, Larkin, Brenda1, Gordon, Ingelise1, Bailer, Robert T.1, Poretz, Donald M.3, Sarwar, Uzma1, Kabadi, Alisha1, Koup, Richard1, Mascola, John R.1, Graham, Barney S.1 |
|---|---|
| Zdroj: | Contemporary Clinical Trials. Sep2015, Vol. 44, p112-118. 7p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|
Full Text from ScienceDirect